DIABNEXT Revenue and Competitors

DIABNEXT® develops a Next-Generation Diabetes A.I. that is a revolution in Diabetes care. Mobile solutions, cloud technology, and connected devices are converging to create a new Artificial Intelligence that optimizes Diabetes and Pre-Diabetes Management. With scientists, statisticians, engineers, specialist healthcare professionals and nutritionists on board, the company has built DIABNEXT®, the first Diabetes A.I. that enables unique personalized metric analysis and decision making tools for doctors and patients to better manage pre-diabetes and diabetes. The DIABNEXT® team is thrilled to be making life better for all the diabetics. DIABNEXT® is the combination of smart sensors, beautiful design, machine learning A.I. and deep understanding of diabetes. DIABNEXT®'s technology creates brand new resources and provides access to an untapped knowledge base for researchers, clinicians, and patients by integrating the latest technologies into a one-stop innovative Diabetes care A.I. Based in Boston, Taipei, Hong Kong and Bangalore, DIABNEXT® owns many patents in Diabetes care, and won two CES Innovation Awards in the Biotech category with its “Bee Smart Diabetes Tracker” in 2015 and in 2017 for its latest innovation CLIPSULIN® .